| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director | Common Stock | 448 | $317K | $708.19 | 02 Jan 2025 | Direct |
| REGENERON PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 1.96K | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2025 | 2 | $0 | 4 | 06 Jan 2025 | Director |
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2024 | 2 | $0 | 4 | 04 Jan 2024 | Director |
| REGN | REGENERON PHARMACEUTICALS, INC. | 08 Sep 2023 | 2 | $0 | 4 | 12 Sep 2023 | Director |
| REGN | REGENERON PHARMACEUTICALS, INC. | 08 Sep 2023 | 0 | $0 | 3 | 12 Sep 2023 | Director |